Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 3
2011 2
2012 1
2014 2
2016 3
2017 2
2018 2
2019 1
2020 9
2021 6
2022 3
2023 4
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion.
Toyoda K, Yasunaga JI, Shichijo T, Arima Y, Tsujita K, Tanaka A, Salah T, Zhang W, Hussein O, Sonoda M, Watanabe M, Kurita D, Nakashima K, Yamada K, Miyoshi H, Ohshima K, Matsuoka M. Toyoda K, et al. Among authors: nakashima k. Blood Cancer Discov. 2023 Sep 1;4(5):374-393. doi: 10.1158/2643-3230.BCD-22-0139. Blood Cancer Discov. 2023. PMID: 37162520 Free PMC article.
CD37 expression in follicular lymphoma.
Yoshimura T, Miyoshi H, Shimono J, Nakashima K, Takeuchi M, Yanagida E, Yamada K, Shimasaki Y, Moritsubo M, Furuta T, Kohno K, Ohshima K. Yoshimura T, et al. Among authors: nakashima k. Ann Hematol. 2022 May;101(5):1067-1075. doi: 10.1007/s00277-022-04785-z. Epub 2022 Feb 16. Ann Hematol. 2022. PMID: 35171311
Digital spatial profiling of CD4+ T cells in classic Hodgkin lymphoma.
Takeuchi M, Miyoshi H, Semba Y, Yamada K, Nakashima K, Sato K, Furuta T, Moritsubo M, Ogura Y, Tanaka K, Imamoto T, Arakawa F, Kohno K, Ohshima K. Takeuchi M, et al. Among authors: nakashima k. Virchows Arch. 2023 Aug;483(2):255-260. doi: 10.1007/s00428-023-03562-1. Epub 2023 Jun 4. Virchows Arch. 2023. PMID: 37270432
Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets.
Koya J, Tanigawa T, Mizuno K, Kim H, Ito Y, Yuasa M, Yamaguchi K, Kogure Y, Saito Y, Shingaki S, Tabata M, Murakami K, Chiba K, Okada A, Shiraishi Y, Marouf A, Liévin R, Chaubard S, Jaccard A, Hermine O, de Leval L, Tournilhac O, Damaj G, Gaulard P, Couronné L, Yasui T, Nakashima K, Miyoshi H, Ohshima K, Kataoka K. Koya J, et al. Among authors: nakashima k. Nat Commun. 2024 Oct 22;15(1):9106. doi: 10.1038/s41467-024-53376-1. Nat Commun. 2024. PMID: 39438472 Free PMC article.
Co-stimulatory and immune checkpoint molecules are important in the tumor microenvironment of Hodgkin-like adult T-cell leukemia/lymphoma.
Takeuchi M, Miyoshi H, Semba Y, Yamada K, Nakashima K, Sato K, Furuta T, Moritsubo M, Ogura Y, Tanaka K, Imamoto T, Arakawa F, Kohno K, Ohshima K. Takeuchi M, et al. Among authors: nakashima k. Haematologica. 2023 Dec 1;108(12):3496-3501. doi: 10.3324/haematol.2023.283163. Haematologica. 2023. PMID: 37439334 Free PMC article. No abstract available.
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma.
Harada S, Ando M, Ando J, Ishii M, Yamaguchi T, Yamazaki S, Toyota T, Ohara K, Ohtaka M, Nakanishi M, Shin C, Ota Y, Nakashima K, Ohshima K, Imai C, Nakazawa Y, Nakauchi H, Komatsu N. Harada S, et al. Among authors: nakashima k. Mol Ther. 2022 Feb 2;30(2):534-549. doi: 10.1016/j.ymthe.2021.10.006. Epub 2021 Oct 8. Mol Ther. 2022. PMID: 34628050 Free PMC article.
Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma.
Mishina T, Miyoshi H, Takeuchi M, Miyawaki K, Nakashima K, Yamada K, Moritsubo M, Inoue-Mitsuyama K, Shimasaki Y, Imamoto T, Kawamoto K, Furuta T, Kohno K, Kato K, Akashi K, Ohshima K. Mishina T, et al. Among authors: nakashima k. Pathol Res Pract. 2024 Feb;254:155117. doi: 10.1016/j.prp.2024.155117. Epub 2024 Jan 10. Pathol Res Pract. 2024. PMID: 38262270
Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma.
Arakawa F, Miyoshi H, Yoshida N, Nakashima K, Watatani Y, Furuta T, Yamada K, Moritsubo M, Takeuchi M, Yanagida E, Shimasaki Y, Kohno K, Kataoka K, Ohshima K. Arakawa F, et al. Among authors: nakashima k. Cancer Med. 2021 Oct;10(19):6786-6794. doi: 10.1002/cam4.4200. Epub 2021 Sep 3. Cancer Med. 2021. PMID: 34477310 Free PMC article.
42 results